Renaissance Technologies (RenTech)'s AVDL Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 273,600 shares of Avadel Pharmaceuticals plc (AVDL) worth $5.9 M, representing 0.01% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in AVDL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 686,373 shares. Largest reduction occurred in Q3 2018, reducing 469,935 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Avadel Pharmaceuticals plc (AVDL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avadel Pharmaceuticals plc (AVDL) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -282,500 | Reduce 50.80% | 273,600 | $21.55 |
| Q3 2025 | +302,500 | Add 119.28% | 556,100 | $15.27 |
| Q2 2025 | -87,400 | Reduce 25.63% | 253,600 | $8.85 |
| Q1 2025 | -46,800 | Reduce 12.07% | 341,000 | $7.83 |
| Q4 2024 | +366,300 | Add 1703.72% | 387,800 | $10.51 |
| Q3 2024 | -42,896 | Reduce 66.61% | 21,500 | $13.12 |
| Q2 2024 | -341,610 | Reduce 84.14% | 64,396 | $14.06 |
| Q1 2024 | -219,100 | Reduce 35.05% | 406,006 | $16.89 |
| Q4 2023 | -113,800 | Reduce 15.40% | 625,106 | $14.12 |
| Q3 2023 | +46,800 | Add 6.76% | 738,906 | $10.30 |
| Q2 2023 | -127,648 | Reduce 15.57% | 692,106 | $0.02 |
| Q1 2023 | +133,948 | Add 19.53% | 819,754 | $0.01 |
| Q4 2022 | -103,100 | Reduce 13.07% | 685,806 | $0.01 |
| Q3 2022 | -65,100 | Reduce 7.62% | 788,906 | $5.01 |
| Q2 2022 | +99,700 | Add 13.22% | 854,006 | $2.44 |
| Q1 2022 | -91,500 | Reduce 10.82% | 754,306 | $6.83 |
| Q4 2021 | -7,500 | Reduce 0.88% | 845,806 | $8.08 |
| Q3 2021 | -23,200 | Reduce 2.65% | 853,306 | $9.80 |
| Q2 2021 | -52,800 | Reduce 5.68% | 876,506 | $6.73 |
| Q1 2021 | -117,000 | Reduce 11.18% | 929,306 | $9.04 |
| Q4 2020 | -190,377 | Reduce 15.39% | 1.05 M | $6.68 |
| Q3 2020 | -101,808 | Reduce 7.61% | 1.24 M | $5.04 |
| Q2 2020 | +432,685 | Add 47.77% | 1.34 M | $8.08 |
| Q1 2020 | +51,800 | Add 6.07% | 905,806 | $7.94 |
| Q4 2019 | +32,000 | Add 3.89% | 854,006 | $7.55 |
| Q3 2019 | +19,400 | Add 2.42% | 822,006 | $4.16 |
| Q2 2019 | +144,270 | Add 21.91% | 802,606 | $2.89 |
| Q1 2019 | +36,836 | Add 5.93% | 658,336 | $1.44 |
| Q4 2018 | +42,365 | Add 7.32% | 621,500 | $2.58 |
| Q3 2018 | -469,935 | Reduce 44.80% | 579,135 | $4.39 |
| Q2 2018 | +267,270 | Add 34.19% | 1.05 M | $6.13 |
| Q1 2018 | -362,800 | Reduce 31.70% | 781,800 | $7.29 |
| Q4 2017 | +320,900 | Add 38.96% | 1.14 M | $8.20 |
| Q3 2017 | +125,427 | Add 17.96% | 823,700 | $10.50 |
| Q2 2017 | +686,373 | Add 5767.84% | 698,273 | $11.03 |
| Q1 2017 | +11,900 | New Buy | 11,900 | $9.66 |
Renaissance Technologies (RenTech)'s Avadel Pharmaceuticals plc Investment FAQs
Renaissance Technologies (RenTech) first purchased Avadel Pharmaceuticals plc (AVDL) in Q1 2017, acquiring 11,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Avadel Pharmaceuticals plc (AVDL) for 36 quarters since Q1 2017.
Renaissance Technologies (RenTech)'s largest addition to Avadel Pharmaceuticals plc (AVDL) was in Q2 2017, adding 698,273 shares worth $7.7 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 273,600 shares of Avadel Pharmaceuticals plc (AVDL), valued at approximately $5.9 M.
As of the Q4 2025 filing, Avadel Pharmaceuticals plc (AVDL) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Avadel Pharmaceuticals plc (AVDL) was 1,338,491 shares, as reported at the end of Q2 2020.